FUJIFILM Diosynth Biotechnologies, a world leading contract development and manufacturing organization (CDMO) for biologics, vaccines, and advanced therapies, held a groundbreaking ceremony today to celebrate the start of its new expansion project to transform the Denmark site into the largest end-to-end CDMO in Europe1. The expansion project will strengthen FUJIFILM Diosynth Biotechnologies’ cell culture manufacturing services in Denmark and create 450 new jobs.
Participating in the ceremony were Jeppe Kofod, Danish Minister of Foreign Affairs, Kirsten Jensen, Mayor, Hillerød municipality, Manabu Miyagawa, Japanese Ambassador to Denmark, and Kenji Sukeno, Chairman, Representative Director and Board Chairman, FUJIFILM Holdings Corporation.
This expansion is funded by a major capital investment of USD 1.6 billion (11 billion Danish kroner) by FUJIFILM Corporation. The expansion will increase the capacity of the current site by adding 8 x 20,000L bioreactors and two downstream processing streams. When the expansion is completed, the site will offer a total of 20 x 20,000L bioreactors for drug substance production complemented by comprehensive drug product and finished goods services.
The expansion project will include sustainability measures to support Fujifilm’s new “Green Value Climate Strategy” with climate action targets including operating on carbon-free energy2 and achieving net zero CO2 emissions by the end of Fiscal Year 2040. Sustainable production enhancements will focus on initiatives aiming to reduce water consumption, to remove operational dependency on fossil fuels, exploring renewable energy sources, operational electrification, and process optimization to reduce natural gas consumption. In addition, FUJIFILM Diosynth Biotechnologies will increase engagement with suppliers and customers to reduce the total value chain carbon emissions.
The expansion is expected to be completed in the summer of 2026.
1Based on Fujifilm research as of September 12, 2022. End-to-end encompasses bulk drug substance production, fill finish and final packaging.
2Direct emission from the company at the manufacturing stage of the product (Scope 1) and indirect emission due to the use of electricity / steam supplied from other companies (Scope 2).